इसराइल - हिब्रू - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (recombinant fc fusion protein –rfixfc) 1000 iu - coagulation factor ix

इसराइल - हिब्रू - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (recombinant fc fusion protein –rfixfc) 2000 iu - coagulation factor ix

इसराइल - हिब्रू - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (recombinant fc fusion protein –rfixfc) 3000 iu - coagulation factor ix

इसराइल - हिब्रू - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (recombinant fc fusion protein –rfixfc) 500 iu - coagulation factor ix

इसराइल - हिब्रू - Ministry of Health

kamada ltd, israel - factor ix - אבקה להכנת תמיסה לזריקה - factor ix 1000 iu/vial - coagulation factor ix, ii, vii and x in combination - coagulation factor ix, ii, vii and x in combination - treatment and prophylaxis of bleeding in patients with haemophilia b ( congenital factor ix deficiency).

इसराइल - हिब्रू - Ministry of Health

dover medical & scientific equipment ltd, israel - factor ix - אבקה וממס להכנת תמיסה להזרקה - factor ix 100 iu/ml - coagulation factor ix - coagulation factor ix - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).

इसराइल - हिब्रू - Ministry of Health

dover medical & scientific equipment ltd, israel - factor ix - אבקה וממס להכנת תמיסה להזרקה - factor ix 100 iu/ml - coagulation factor ix - coagulation factor ix - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).

इसराइल - हिब्रू - Ministry of Health

csl behring ltd., israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein c; protein s antigen - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ii (human) 200 - 480 iu; coagulation factor vii (human) 100 - 250 iu; coagulation factor ix (human- rfixfc) 200 - 310 iu; coagulation factor x (human) 220 - 600 iu; protein c 150 - 450 iu; protein s antigen 120 - 380 iu - coagulation factor ix, ii, vii and x in combination - coagulation factor ix, ii, vii and x in combination - -treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

इसराइल - हिब्रू - Ministry of Health

dover medical & scientific equipment ltd, israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein; protein c; protein s antigen - אבקה וממס להכנת תמיסה לאינפוזיה - coagulation factor ix (human- rfixfc) 25 iu/ml; coagulation factor ii (human) 14 - 38 iu/ml; coagulation factor vii (human) 9 - 24 iu/ml; coagulation factor x (human) 18 - 30 iu/ml; protein 13 - 41 mg/ml; protein c 13 - 31 iu/ml; protein s antigen 12 - 32 iu/ml - coagulation factor ix, ii, vii and x in combination

इसराइल - हिब्रू - Ministry of Health

bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 1000 iu - coagulation factor viii